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ABSTRACT 
MicroRNAs (miRNA) are 21–23 nucleotide molecules not translated into proteins that bind 
and target the 3′ untranslated regions of mRNA. These characteristics make them a possible 
tool for inhibiting protein translation. Different cellular pathways involved in cancer 
development, such as cellular proliferation, apoptosis, and migration, are regulated by 
miRNAs. The objective of this review is to discuss various miRNAs involved in breast cancer 
in detail as well as different therapeutic strategies from the clinic to industry. A comprehensive 
discussion is provided on various miRNAs involved in breast cancer development, progression, 
and metastasis as well as the roles, targets, and related therapeutic strategies of different 
miRNAs associated with breast cancer. miRNAs known to be clinically useful for the diagnosis 
and prognosis of breast cancer are also discussed. Different strategies and challenges, including 
nucleic acid-based (miRNA mimics, antagomiRs, and miRNA sponges) and drug-based (drug 
resistance, drugs/miRNA interaction, nanodelivery, and sensing systems) approaches to 
suppress specific oncogenes and/or activate target tumor suppressors are discussed. In contrast 
to other articles written on the same topic, this review focuses on the therapeutic and clinical 
value of miRNAs as well as their corresponding targets in order to explore how these strategies 
can overcome breast cancer, which is the second most frequent type of cancer worldwide. This 
review focuses on promising and validated miRNAs involved in breast cancer. In particular, 
two miRNAs, miR-21 and miR-34, are discussed as the most promising targets for RNA-based 
therapy in non-invasive and invasive breast cancer, respectively. Finally, relevant and 
commercialized therapeutic strategies are highlighted. 
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